Executive Summary
Public Joint Stock Company Acron, together with its subsidiaries, manufactures, distributes, and sells chemical fertilizers and related mineral primary and by-products. More Details
Rewards
Risk Analysis
Snowflake Analysis
Reasonable growth potential average dividend payer.
Similar Companies
Share Price & News
How has Acron's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AKRN is less volatile than 75% of Russian stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: AKRN's weekly volatility (2%) has been stable over the past year.
Market Performance
7 Day Return
-1.5%
AKRN
-0.7%
RU Chemicals
1.2%
RU Market
1 Year Return
21.4%
AKRN
7.5%
RU Chemicals
-1.5%
RU Market
Return vs Industry: AKRN exceeded the Russian Chemicals industry which returned 9% over the past year.
Return vs Market: AKRN exceeded the Russian Market which returned -1.8% over the past year.
Shareholder returns
| AKRN | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.5% | -0.7% | 1.2% |
| 30 Day | -6.3% | 3.2% | 12.8% |
| 90 Day | 1.2% | 2.7% | 6.4% |
| 1 Year | 33.5%21.4% | 14.4%7.5% | 5.3%-1.5% |
| 3 Year | 97.4%56.7% | 51.8%27.0% | 53.1%26.9% |
| 5 Year | 168.6%76.8% | 74.4%34.5% | 122.0%69.7% |
Long-Term Price Volatility Vs. Market
How volatile is Acron's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Is Public Joint Stock Company Acron's (MCX:AKRN) 10% ROE Better Than Average?2 weeks ago | Simply Wall St
How Many Public Joint Stock Company Acron (MCX:AKRN) Shares Do Institutions Own?1 month ago | Simply Wall St
These 4 Measures Indicate That Acron (MCX:AKRN) Is Using Debt ExtensivelyValuation
Is Acron undervalued compared to its fair value and its price relative to the market?
38.12x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: AKRN (RUB6010) is trading above our estimate of fair value (RUB2779.42)
Significantly Below Fair Value: AKRN is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: AKRN is poor value based on its PE Ratio (38.1x) compared to the RU Chemicals industry average (11.9x).
PE vs Market: AKRN is poor value based on its PE Ratio (38.1x) compared to the Russian market (11.4x).
Price to Earnings Growth Ratio
PEG Ratio: AKRN is poor value based on its PEG Ratio (1.9x)
Price to Book Ratio
PB vs Industry: AKRN is overvalued based on its PB Ratio (5.8x) compared to the RU Chemicals industry average (1.3x).
Next Steps
Future Growth
How is Acron forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
20.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AKRN's forecast earnings growth (20.3% per year) is above the savings rate (8.3%).
Earnings vs Market: AKRN's earnings (20.3% per year) are forecast to grow slower than the Russian market (26.1% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AKRN's revenue (8.4% per year) is forecast to grow faster than the Russian market (7.6% per year).
High Growth Revenue: AKRN's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AKRN's Return on Equity is forecast to be high in 3 years time (36.8%)
Next Steps
Past Performance
How has Acron performed over the past 5 years?
-2.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AKRN has high quality earnings.
Growing Profit Margin: AKRN's current net profit margins (5.5%) are lower than last year (22.2%).
Past Earnings Growth Analysis
Earnings Trend: AKRN's earnings have declined by 2.4% per year over the past 5 years.
Accelerating Growth: AKRN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AKRN had negative earnings growth (-76.9%) over the past year, making it difficult to compare to the Chemicals industry average (-65.8%).
Return on Equity
High ROE: AKRN's Return on Equity (10.2%) is considered low.
Next Steps
Financial Health
How is Acron's financial position?
Financial Position Analysis
Short Term Liabilities: AKRN's short term assets (RUB53.8B) exceed its short term liabilities (RUB45.6B).
Long Term Liabilities: AKRN's short term assets (RUB53.8B) do not cover its long term liabilities (RUB107.0B).
Debt to Equity History and Analysis
Debt Level: AKRN's debt to equity ratio (177.2%) is considered high.
Reducing Debt: AKRN's debt to equity ratio has increased from 86.7% to 177.2% over the past 5 years.
Debt Coverage: AKRN's debt is not well covered by operating cash flow (18.7%).
Interest Coverage: AKRN's interest payments on its debt are well covered by EBIT (11.8x coverage).
Balance Sheet
Next Steps
Dividend
What is Acron current dividend yield, its reliability and sustainability?
8.87%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: AKRN's dividend (8.87%) is higher than the bottom 25% of dividend payers in the Russian market (3.86%).
High Dividend: AKRN's dividend (8.87%) is in the top 25% of dividend payers in the Russian market (8.01%)
Stability and Growth of Payments
Stable Dividend: AKRN's dividend payments have been volatile in the past 10 years.
Growing Dividend: AKRN's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (274%), AKRN's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: AKRN's dividends in 3 years are forecast to be covered by earnings (66.1% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
9.2yrs
Average management tenure
CEO
Vladimir Kunitsky (72 yo)
9.92yrs
Tenure
Mr. Vladimir Yakovlevich Kunitsky has been the Chairman of the Managing Board and Chief Executive Officer of Public PJSC Acron (formerly known as Joint Stock Company Acron) since 2011 and has been its Memb...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Senior VP | 5.42yrs | no data | 0.053% RUB 120.5m | |
| Chairman of the Management Board & CEO | 9.92yrs | no data | 0.047% RUB 105.7m | |
| Deputy Chairman of the Board | 5.42yrs | no data | no data | |
| VP of Finance & Economics and Member of the Managing Board | 2yrs | no data | no data | |
| Finance Director & Member of the Managing Board | 10.67yrs | no data | 0.0022% RUB 4.9m | |
| Vice President of Foreign Economic Affairs & Member of the Managing Board | 8.42yrs | no data | no data | |
| VP of Human Resources & Special Projects and Member of the Managing Board | 6.92yrs | no data | no data | |
| VP of Domestic Business & Agricultural Projects and Member of the Managing Board | 2yrs | no data | no data | |
| Chief Accountant | no data | no data | no data | |
| Head of Investor Relations | no data | no data | no data | |
| CEO Advisor & Director | 12.92yrs | no data | no data | |
| Head of the Protocol Unit | no data | no data | no data |
9.2yrs
Average Tenure
51yo
Average Age
Experienced Management: AKRN's management team is seasoned and experienced (9.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Senior VP | 5.42yrs | no data | 0.053% RUB 120.5m | |
| Deputy Chairman of the Board | 5.42yrs | no data | no data | |
| CEO Advisor & Director | 12.92yrs | no data | no data | |
| CEO Advisor & Director | 4.58yrs | no data | no data | |
| Senior Independent Director | 4.58yrs | no data | no data | |
| Independent Director | 5.58yrs | no data | no data | |
| Independent Director | 5.58yrs | no data | no data |
5.4yrs
Average Tenure
60yo
Average Age
Experienced Board: AKRN's board of directors are considered experienced (5.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Public Joint Stock Company Acron's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Public Joint Stock Company Acron
- Ticker: AKRN
- Exchange: MISX
- Founded: 1992
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Market Cap: ₽227.201b
- Shares outstanding: 37.45m
- Website: https://www.acron.ru
Location
- Public Joint Stock Company Acron
- World Trade Centre
- 12 Krasnopresnenskaya Naberezhnaya
- Moscow
- Moskovskaya obl.
- 123610
- Russia
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| AKRN | MISX (Micex - Rts) | Yes | Ordinary Shares | RU | RUB | Jan 1996 |
| AKRN | LSE (London Stock Exchange) | GDR 10 GDRS REP 1 ORD 'REG S' | GB | USD | Aug 2008 | |
| AKRNL | BATS-CHIXE (BATS 'Chi-X Europe') | GDR 10 GDRS REP 1 ORD 'REG S' | GB | USD | Aug 2008 |
Biography
Public Joint Stock Company Acron, together with its subsidiaries, manufactures, distributes, and sells chemical fertilizers and related mineral primary and by-products. The company provides mineral fertili...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/12/04 18:12 |
| End of Day Share Price | 2020/12/04 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.